يعرض 2,241 - 2,260 نتائج من 13,825 نتيجة بحث عن '(( significantly increased decrease ) OR ( significant ((small decrease) OR (point decrease)) ))', وقت الاستعلام: 0.63s تنقيح النتائج
  1. 2241
  2. 2242
  3. 2243
  4. 2244
  5. 2245
  6. 2246
  7. 2247
  8. 2248

    Comparison of demographic features. حسب Yueju Cai (20978633)

    منشور في 2025
    "…Additionally, a decrease in birth weight was significantly linked to an increased risk of readmission (OR = 0.998, P = 0.013), although the effect size was relatively small.…"
  9. 2249

    Data. حسب Yueju Cai (20978633)

    منشور في 2025
    "…Additionally, a decrease in birth weight was significantly linked to an increased risk of readmission (OR = 0.998, P = 0.013), although the effect size was relatively small.…"
  10. 2250

    Comparison of examination test and treatment. حسب Yueju Cai (20978633)

    منشور في 2025
    "…Additionally, a decrease in birth weight was significantly linked to an increased risk of readmission (OR = 0.998, P = 0.013), although the effect size was relatively small.…"
  11. 2251
  12. 2252
  13. 2253
  14. 2254
  15. 2255
  16. 2256
  17. 2257

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  18. 2258

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  19. 2259

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  20. 2260

    Flow of participants through the study. حسب Sedighe Esmaeilzadeh (21100668)

    منشور في 2025
    "…Furthermore, melatonin significantly decreased sleep latency, exhibiting a large effect size, and contributed to a medium reduction in the use of sleep medications. …"